nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—Donepezil—HRH3—narcolepsy	0.0831	0.814	CrCbGaD
Doxazosin—Donepezil—HTR2A—narcolepsy	0.019	0.186	CrCbGaD
Doxazosin—KCNH6—forebrain—narcolepsy	0.0181	0.162	CbGeAlD
Doxazosin—KCNH7—brain—narcolepsy	0.0106	0.0944	CbGeAlD
Doxazosin—ADRA1D—forebrain—narcolepsy	0.01	0.0898	CbGeAlD
Doxazosin—KCNH6—brain—narcolepsy	0.00752	0.0673	CbGeAlD
Doxazosin—ADRA1A—brainstem—narcolepsy	0.00598	0.0535	CbGeAlD
Doxazosin—ADRA1A—forebrain—narcolepsy	0.00577	0.0516	CbGeAlD
Doxazosin—KCNH2—forebrain—narcolepsy	0.00557	0.0498	CbGeAlD
Doxazosin—ADRA2A—forebrain—narcolepsy	0.00439	0.0392	CbGeAlD
Doxazosin—ADRA1B—brain—narcolepsy	0.00426	0.0381	CbGeAlD
Doxazosin—ADRA1D—brain—narcolepsy	0.00417	0.0373	CbGeAlD
Doxazosin—KCNH2—medulla oblongata—narcolepsy	0.00403	0.036	CbGeAlD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00402	0.00511	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00398	0.00506	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00396	0.00504	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00388	0.00494	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00387	0.00493	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00387	0.00493	CbGpPWpGaD
Doxazosin—ADRA1B—G alpha (q) signalling events—TRH—narcolepsy	0.00378	0.00481	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00374	0.00476	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00369	0.00469	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00369	0.00469	CbGpPWpGaD
Doxazosin—KCNH2—midbrain—narcolepsy	0.00368	0.0329	CbGeAlD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00357	0.00454	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00357	0.00454	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—P2RY11—narcolepsy	0.00356	0.00453	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00355	0.00451	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Other—HTR2A—narcolepsy	0.00354	0.0045	CbGpPWpGaD
Doxazosin—CYP2D6—brainstem—narcolepsy	0.00352	0.0315	CbGeAlD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00345	0.00439	CbGpPWpGaD
Doxazosin—CYP2D6—forebrain—narcolepsy	0.0034	0.0304	CbGeAlD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00338	0.0043	CbGpPWpGaD
Doxazosin—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.00336	0.00427	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00332	0.00422	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00332	0.00422	CbGpPWpGaD
Doxazosin—ADRA1D—G alpha (q) signalling events—NPS—narcolepsy	0.00331	0.00421	CbGpPWpGaD
Doxazosin—ADRA1D—G alpha (q) signalling events—TAC1—narcolepsy	0.00331	0.00421	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0033	0.0042	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0032	0.00408	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.0032	0.00406	CbGpPWpGaD
Doxazosin—ADRA2A—medulla oblongata—narcolepsy	0.00317	0.0283	CbGeAlD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00309	0.00392	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—HCRTR2—narcolepsy	0.00306	0.00389	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—HCRTR1—narcolepsy	0.00306	0.00389	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—PENK—narcolepsy	0.00305	0.00389	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—HCRT—narcolepsy	0.00303	0.00385	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00301	0.00383	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.003	0.00382	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00296	0.00376	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00296	0.00376	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—P2RY11—narcolepsy	0.00296	0.00376	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00294	0.00374	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00293	0.00373	CbGpPWpGaD
Doxazosin—ADRA2A—midbrain—narcolepsy	0.0029	0.0259	CbGeAlD
Doxazosin—ADRA1B—G alpha (q) signalling events—NPS—narcolepsy	0.00274	0.00349	CbGpPWpGaD
Doxazosin—ADRA1B—G alpha (q) signalling events—TAC1—narcolepsy	0.00274	0.00349	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00272	0.00347	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00272	0.00346	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00272	0.00346	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—PENK—narcolepsy	0.0027	0.00343	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00264	0.00336	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00263	0.00334	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00261	0.00332	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00256	0.00326	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—HCRTR2—narcolepsy	0.00253	0.00321	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—HCRTR1—narcolepsy	0.00253	0.00321	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—HCRT—narcolepsy	0.00251	0.0032	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0025	0.00318	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00246	0.00312	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00246	0.00312	CbGpPWpGaD
Doxazosin—ABCB1—forebrain—narcolepsy	0.00244	0.0219	CbGeAlD
Doxazosin—ADRA2A—GPCR ligand binding—P2RY11—narcolepsy	0.00244	0.0031	CbGpPWpGaD
Doxazosin—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00244	0.0031	CbGpPWpGaD
Doxazosin—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00244	0.0031	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00243	0.00309	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.0024	0.00306	CbGpPWpGaD
Doxazosin—ADRA1A—brain—narcolepsy	0.00239	0.0214	CbGeAlD
Doxazosin—KCNH2—brain—narcolepsy	0.00231	0.0207	CbGeAlD
Doxazosin—ADRA1D—GPCR ligand binding—TRH—narcolepsy	0.0023	0.00292	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.00228	0.0029	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00227	0.00289	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00225	0.00286	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—PENK—narcolepsy	0.00224	0.00285	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00223	0.00284	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00222	0.00283	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00219	0.00279	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00219	0.00279	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00219	0.00279	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00218	0.00277	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00218	0.00277	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00211	0.00269	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00208	0.00265	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00208	0.00265	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.00207	0.00264	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00206	0.00263	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00201	0.00256	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—HRH3—narcolepsy	0.00201	0.00256	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00199	0.00253	CbGpPWpGaD
Doxazosin—ADRA1D—G alpha (q) signalling events—HTR2A—narcolepsy	0.00199	0.00253	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00195	0.00248	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.00191	0.00242	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00189	0.00241	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00189	0.00241	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.00185	0.00235	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—P2RY11—narcolepsy	0.00183	0.00233	CbGpPWpGaD
Doxazosin—ADRA2A—brain—narcolepsy	0.00182	0.0163	CbGeAlD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00182	0.00231	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00182	0.00231	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00181	0.0023	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00178	0.00226	CbGpPWpGaD
Doxazosin—ABCB1—medulla oblongata—narcolepsy	0.00177	0.0158	CbGeAlD
Doxazosin—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00173	0.0022	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00173	0.0022	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—HCRT—narcolepsy	0.00171	0.00218	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00171	0.00217	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00169	0.00215	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00167	0.00213	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.00167	0.00213	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—TAC1—narcolepsy	0.00167	0.00212	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—NPS—narcolepsy	0.00167	0.00212	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00166	0.00211	CbGpPWpGaD
Doxazosin—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00165	0.0021	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00161	0.00205	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00161	0.00205	CbGpPWpGaD
Doxazosin—ABCB1—midbrain—narcolepsy	0.00161	0.0144	CbGeAlD
Doxazosin—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00157	0.002	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00157	0.002	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00157	0.002	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00155	0.00198	CbGpPWpGaD
Doxazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00154	0.00196	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00154	0.00195	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00154	0.00195	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.00153	0.00194	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.00152	0.00193	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0015	0.00191	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0015	0.00191	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00148	0.00189	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00148	0.00189	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00148	0.00188	CbGpPWpGaD
Doxazosin—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00147	0.00187	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00143	0.00182	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00143	0.00182	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.00142	0.00181	CbGpPWpGaD
Doxazosin—CYP2D6—brain—narcolepsy	0.00141	0.0126	CbGeAlD
Doxazosin—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.0014	0.00178	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.0014	0.00178	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.00139	0.00176	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.00138	0.00176	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.00138	0.00176	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.00138	0.00175	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.00138	0.00175	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00137	0.00175	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00135	0.00171	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00132	0.00168	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00131	0.00167	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.0013	0.00165	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.0013	0.00165	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.0013	0.00165	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.00129	0.00164	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00128	0.00162	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.00127	0.00161	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00126	0.00161	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.00125	0.00159	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00123	0.00156	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00123	0.00156	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.00118	0.0015	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.00117	0.00149	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.00115	0.00146	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00115	0.00146	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.00114	0.00145	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.00114	0.00145	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.00114	0.00145	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00113	0.00144	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00113	0.00143	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00112	0.00143	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.00112	0.00142	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.00112	0.00142	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00109	0.00139	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.00108	0.00137	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.00108	0.00137	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.00106	0.00135	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00105	0.00134	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.00105	0.00133	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CHKB—narcolepsy	0.00104	0.00132	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.00103	0.00131	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00102	0.0013	CbGpPWpGaD
Doxazosin—ABCB1—brain—narcolepsy	0.00101	0.00907	CbGeAlD
Doxazosin—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.001	0.00128	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.000978	0.00124	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000971	0.00124	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.000956	0.00122	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.000949	0.00121	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.000944	0.0012	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.000943	0.0012	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.000943	0.0012	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.000928	0.00118	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.000928	0.00118	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.000918	0.00117	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000903	0.00115	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.000896	0.00114	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.000889	0.00113	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.000868	0.0011	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.000857	0.00109	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.000856	0.00109	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.000856	0.00109	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.000839	0.00107	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.000833	0.00106	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.000824	0.00105	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.000824	0.00105	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.000818	0.00104	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000807	0.00103	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—TRH—narcolepsy	0.000807	0.00103	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.000796	0.00101	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.000782	0.000995	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.000782	0.000995	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	0.000779	0.000991	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	0.000766	0.000974	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	0.000766	0.000974	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.000762	0.00097	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.000762	0.000969	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	0.00074	0.000941	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.00074	0.000941	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CHKB—narcolepsy	0.000737	0.000938	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CHKB—narcolepsy	0.000719	0.000915	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.00071	0.000904	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.00071	0.000904	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	0.000708	0.0009	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CPT1B—narcolepsy	0.000707	0.0009	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.000696	0.000885	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.000695	0.000884	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.000695	0.000884	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	0.000687	0.000874	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.000679	0.000864	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CHKB—narcolepsy	0.000678	0.000862	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.000677	0.000861	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	0.000646	0.000821	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	0.000646	0.000821	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.000631	0.000803	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.000631	0.000803	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HCRT—narcolepsy	0.000629	0.0008	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.00061	0.000776	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.000603	0.000768	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	0.000586	0.000746	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—NPS—narcolepsy	0.000586	0.000746	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.000578	0.000735	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000567	0.000721	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PENK—narcolepsy	0.000561	0.000713	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.000515	0.000655	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000513	0.000653	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.000506	0.000644	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000506	0.000643	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000506	0.000643	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000501	0.000637	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CPT1B—narcolepsy	0.000489	0.000622	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TRH—narcolepsy	0.000477	0.000606	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000471	0.000599	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000461	0.000586	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.00045	0.000572	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000427	0.000544	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.00042	0.000534	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.00042	0.000534	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000418	0.000532	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HRH3—narcolepsy	0.000418	0.000532	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000398	0.000507	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.000388	0.000494	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.00038	0.000483	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000373	0.000474	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000373	0.000474	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000353	0.000449	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NPS—narcolepsy	0.000346	0.000441	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TAC1—narcolepsy	0.000346	0.000441	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.000304	0.000387	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.000252	0.000321	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000224	0.000285	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	0.000208	0.000265	CbGpPWpGaD
